Clinical Trials on Familial Prostate Cancer
Total 54108 results
-
Centre Jean PerrinTerminatedProstate Cancer Metastatic Castration ResistantFrance
-
Zenith EpigeneticsCompletedMetastatic Castration-Resistant Prostate CancerUnited States
-
University of Illinois at Urbana-ChampaignUniversity of Toronto; Princess Margaret Hospital, Canada; Toronto Sunnybrook...CompletedReducing Sedentary Behavior Among Prostate Cancer Survivors on Androgen Deprivation Therapy (RiseTx)Cancer | Sedentary Lifestyle | Prostate Cancer | Prostate Neoplasm
-
Gustave Roussy, Cancer Campus, Grand ParisSanofiUnknownMetastatic Castration-resistant Prostate CancerFrance
-
The Christie NHS Foundation TrustAstraZenecaCompletedMetastatic Castration Resistant Prostate CancerUnited Kingdom
-
Nerviano Medical SciencesCompletedMetastatic Hormone Refractory Prostate CancerItaly
-
University of HohenheimUniversity Hospital Tuebingen; Quercegen PharmaceuticalsUnknownPrimary Prevention of Prostate CancerGermany
-
Centre Francois BaclesseTerminatedProstate Cancer With Intermediate RiskFrance
-
National Cancer Institute (NCI)CompletedStage IIA Prostate Cancer AJCC v7 | PSA Level Less Than Ten | Stage I Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7 | Stage II Prostate Cancer AJCC v7 | PSA Level Less Than or Equal to FifteenUnited States
-
Mamta ParikhNational Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Advanced Prostate AdenocarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Progenics Pharmaceuticals, Inc.Not yet recruitingProstate Adenocarcinoma | Castration Resistant Prostate Cancer | Castration Sensitive Prostate CancerUnited States
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)RecruitingProstate Adenocarcinoma | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
University of WashingtonNational Cancer Institute (NCI)Active, not recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IVB Prostate Cancer AJCC v8United States
-
National Cancer Institute (NCI)TerminatedProstate Adenocarcinoma | Stage IIA Prostate Cancer AJCC v7 | Stage IIB Prostate Cancer AJCC v7United States
-
National Cancer Institute (NCI)TerminatedRecurrent Prostate Cancer | Adenocarcinoma of the Prostate | Stage IV Prostate CancerUnited States
-
RenJi HospitalNot yet recruitingProstate Cancer | Chemotherapy Effect | Hormone Sensitive Prostate Cancer | Locally Advanced Prostate Carcinoma
-
IRCCS San RaffaeleRecruitingSuspicion of Prostate Cancer With a Positive Multiparametric Magnetic Resonance of the ProstateItaly
-
National Cancer Institute (NCI)CompletedRecurrent Prostate Carcinoma | Stage IV Prostate Cancer AJCC v7United States
-
University of Kansas Medical CenterNational Cancer Institute (NCI)Not yet recruitingRelugolix in Combination With Radiation Therapy for Treating Patients With High Risk Prostate CancerStage IV Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8United States
-
Chang Gung Memorial HospitalRecruiting
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)RecruitingMetastatic Castration-resistant Prostate CancerChina
-
Allife Medical Science and Technology Co., Ltd.Tianjin People's HospitalRecruitingMetastatic Castration-resistant Prostate CancerChina
-
Exosome Diagnostics, Inc.Yale UniversitySuspendedMetastatic Castrate Resistant Prostate CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingMetastatic Castration Resistant Prostate CancerChina
-
Dizal PharmaceuticalsTerminatedMetastatic Castration Resistant Prostate CancerUnited States, Korea, Republic of
-
Royal North Shore HospitalTerminatedMetastatic Castrate- Resistant Prostate CancerAustralia
-
Jodi Layton, MDEMD SeronoTerminatedMetastatic Castration-resistant Prostate CancerUnited States
-
Janssen-Cilag Farmaceutica Ltda.CompletedMetastatic Castration-resistant Prostate CancerBrazil
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United Kingdom; National Institute for Health...Active, not recruiting
-
SOTIO a.s.CompletedMetastatic Castration-resistant Prostate CancerUnited States, Spain, United Kingdom, Germany, Serbia, Portugal, Lithuania, Slovakia, Hungary, Netherlands, Croatia, France, Czechia, Poland, Austria, Belarus, Belgium, Bulgaria, Denmark, Italy, Latvia, Sweden
-
Novartis PharmaceuticalsCompletedMetastatic Hormone Refractory Prostate CancerUnited States, France, Spain, Belgium, Singapore, Italy, Australia, Germany
-
Gilead SciencesTerminatedMetastatic Castrate-Resistant Prostate CancerUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...United States Department of DefenseCompletedCastration Resistant Metastatic Prostate CancerUnited States
-
Hinova Pharmaceuticals Inc.West China HospitalCompletedMetastatic Castration Resistant Prostate CancerChina
-
British Columbia Cancer AgencyCompletedMetastatic Castration-Resistant Prostate CancerCanada
-
Centro Nacional de Investigaciones Oncologicas...UnknownAdvanced Prostate Cancer | Docetaxel | CabazitaxelSpain
-
MedImmune LLCCompletedMetastatic Castration Resistant Prostate CancerUnited States, Switzerland, United Kingdom
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownMetastatic Castration-resistant Prostate CancerChina
-
Paul Mathew, MDHoosier Cancer Research Network; Tesaro, Inc.TerminatedMetastatic Prostate CancerUnited States
-
Astellas Pharma a/sCompletedMetastatic Castration Resistant Prostate CancerSweden
-
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.CompletedMetastatic Castration Resistant Prostate CancerChina
-
Astellas Pharma Europe Ltd.Medivation, Inc.CompletedMetastatic Castration Resistant Prostate CancerCzechia, Netherlands, Denmark, Italy, Austria, Belgium, Bulgaria, France, Germany, Greece, Hungary, Ireland, Portugal, Slovenia, Spain, United Kingdom
-
Innocrin PharmaceuticalCompletedCastration-resistant Prostate Cancer | CRPCUnited States
-
University of Alabama at BirminghamAmgenCompletedPhase 2 Trial of Carfilzomib for Metastatic Castration-resistant Prostate Cancer Following TreatmentMetastatic Castration-resistant Prostate CancerUnited States
-
Astellas Pharma Europe B.V.Medivation, Inc.CompletedMetastatic Castration-Resistant Prostate CancerBelgium, France, Germany, Spain, United Kingdom
-
Astellas Pharma Global Development, Inc.Medivation, Inc.TerminatedMetastatic Castration Resistant Prostate CancerUnited States
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)UnknownMetastatic Castration-resistant Prostate CancerChina
-
Institut Paoli-CalmettesNovartisTerminatedNon Castrate Metastatic Prostate CancerFrance
-
Rahul AggarwalSanofiCompletedMetastatic Castration-resistant Prostate CancerUnited States
-
Cellular Biomedicine Group Ltd.Fudan UniversityUnknownMetastatic Castration-resistant Prostate CancerChina